Clinicopathological Profiles and Treatment Patterns in Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study
Pakistan Journal of Gastroenterology · 2026
DOI: 10.63521/91hrwp36 ↗At a glance
Kohortenstudie in Pakistan Journal of Gastroenterology, 2026. Written by Junaid Mushtaq and 5 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Despite advancements made in oncology over recent decades, HCC still is one of the major causes of mortality from neoplastic diseases.Heterogeneity exists among clinicopathological characteristics and responses to therapy.
Objective
To evaluate clinicopathological characteristics and treatment patterns in HCC cases as well as the potential predictors of tumor burden, severity of hepatic dysfunction, and survival in the patients.
Methods
A retrospective analysis was performed involving 226 adult patients with HCC diagnosed using institutional databases; individuals without sufficient data on their clinicopathological characteristics and therapy were excluded from this investigation.A detailed chart review was used to extract relevant information on the patients' demographic data, etiology of cirrhosis, liver function, tumor burden, biomarkers (AFP, PIVKA-II), and therapy applied.The outcome measures involved the tumor size, biomarker concentrations, therapy modality, and survival.Analyses were performed using the SPSS software version 27.0, including descriptive statistics, comparative analysis, correlations, and regression modeling.Ethical approval was obtained at an institutional level in keeping with the guidelines provided by the Declaration of Helsinki.
Results
The analyzed cohort consisted mainly of males (75.7%) aged 60.7 ± 11.9 years.Patients in our series were more frequently diagnosed with HCV-related disease (46.5%).In addition, most patients suffered from advanced BCLC stage C (53.8%) and retained normal liver functions (Child-Pugh A, 62.8%).Tumor size, advanced Child-Pugh classification, and AFP concentration >400 ng/mL were independently associated with lower survival (p < 0.05).At the same time, there were no differences between groups with regard to tumor characteristics and biomarker concentrations depending on etiology.
Conclusion
Our findings demonstrated that clinicopathological characteristics and patterns of treatment of HCC patients were homogenous regarding etiology, but the tumor size, degree of liver injury, and AFP levels can be considered key prognostic factors.
Cite
APA
Mushtaq, J., Amjad, I., Sarwar, S., Hanif, A., Adeel, M., & Khan, A. A. (2026). Clinicopathological Profiles and Treatment Patterns in Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study. Pakistan Journal of Gastroenterology. https://doi.org/10.63521/91hrwp36
Vancouver
Mushtaq J, Amjad I, Sarwar S, Hanif A, Adeel M, Khan AA. Clinicopathological Profiles and Treatment Patterns in Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study. Pakistan Journal of Gastroenterology. 2026. doi:10.63521/91hrwp36
BibTeX
@article{Mushtaq2026,
author = {Mushtaq, Junaid and Amjad, Ibtesaam and Sarwar, Sehrish and Hanif, Ayesha and Adeel, Muhammad and Khan, Anwar A},
title = {Clinicopathological Profiles and Treatment Patterns in Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study},
journal = {Pakistan Journal of Gastroenterology},
year = {2026},
doi = {10.63521/91hrwp36}
}
EUVIMED